The vesicular monoamine transporter is a transport protein located within the presynaptic cell. Chemical synapses are specialized junctions through which Neurons signal to each other and to non-neuronal cells such as those in Muscles or Glands
Contents |
It comprises the two isoforms:
Substrates for the transporter is mainly noradrenaline, adrenaline and isoprenaline. A protein isoform is a version of a Protein with only small differences to another isoform of the same protein VMAT1 ( Vesicular monoamine transporter 1 is a protein that transports the Monoamine neurotransmitters into Synaptic vesicles In Chromaffin cells The Vesicular Monoamine Transporter 2 or VMAT2 is an Integral membrane protein that acts to transport Monoamines mdashparticularly Neurotransmitters Norepinephrine ( INN) (abbreviated norepi or NE) or noradrenaline ( BAN) (abbreviated NA or NAd) is a Isoprenaline ( INN) or isoproterenol ( USAN, trade names Medihaler-Iso and Isuprel) is a Sympathomimetic beta Adrenergic However, other substrates include dopamine, 5-HT, guanethidine and MPP+. Dopamine is a Hormone and Neurotransmitter occurring in a wide variety of animals including both vertebrates and invertebrates Serotonin (ˌsɛrəˈtoʊnən ( 5-hydroxytryptamine, or 5-HT) is a Monoamine Neurotransmitter synthesized in serotonergic Neurons Guanethidine is an Antihypertensive drug that reduces the release of Catecholamines, such as noradrenaline MPP+ (1- Methyl -4- Phenyl[[pyridine pyridinium]] is a positively charged molecule with Chemical formula C 12 H 12 [1]
It can be inhibited by reserpine and tetrabenazine. Reserpine is an Indole Alkaloid Antipsychotic and Antihypertensive drug that has been used for the control of high blood pressure Tetrabenazine is a drug for the symptomatical treatment of hyperkinetic Movement disorder and is marketed under the trade names Nitoman in Canada and [1]
VMAT is the main target of methamphetamine. The vesicular monoamine transporter is a Transport protein located within the presynaptic cell. By acting as a competitive antagonist, methamphetamine blocks the presynaptic cell's ability to use VMAT to package the above mentioned neurotransmitters into vesicles. A competitive antagonist is a Receptor antagonist that binds to a receptor but does not activate the receptor The result is increased neurotransimtter release that is not dependent on the phasic activity of the presynaptic cell.